The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hi DSM, It would be lovely to see some movement in Moderna.
Hopefully she knows something that we don't.
It's been dribbling downwards for awhile now and only ever seems to bounce up after repeatedly hitting around the $117 / 118 mark.
Wonder if she's just doing a bit of large scale averaging down?
The article says she's lost 17% on Moderna since June 2022, and as it refuses to really break below the support level of $117 maybe this was a good time to get her holdings down to a more achievable price for the future.
If Moderna does get dragged back up by the rising market, or has a breakthrough, I guess her breakeven point will be more likely.
ARK Genomic Revolution ETF was holding 245,399 so the 98,800 is quite a chunk for averaging down, but still only makes up less than 2% of the fund.
Ahh, just realised there's a chat filter to mute some of the noise on this site.
Makes for much more peaceful reading and I might actually get to pick up some new info or gain a bit of knowledge now without having to wade through pages of dull shouty stuff that has nearly made this forum unreadable.
FFS Fela, give it a rest. I occasionally pop onto this site to see if anyone has any new info or actual genuine insights into what is happening with Scottish Mortgage, but instead the chat feed is full of your posts, endlessly telling everyone that they are twats.
Everyone has been pretty civilised in the way that they are dealing with you but your confrontational, keyboard warrior ranting is getting tiresome and actually gets in the way of any genuine discourse.
No doubt you'll now feel the need to sarcastically try to put me down for posting this.
But just for once, have a go at resisting that urge. You might be happier for it.
The Fusion research is very interesting and it'll be fascinating to see what progress can be made, particularly regarding scalability.
With the price in the short term I guess we'll have to see if it can break up through the downward trend line that started in September.
IP Group is currently my worst performing share and I'm almost viewing it as a right-off.
The share price is almost exactly the same as when the company was listed nearly twenty years ago and has been steadily tumbling down from its peak of around 270 pence in February 2015.
The market madness of the last few years, and the listing of Oxford Nanopore dragged the share price up, but since then it has been in steady decline. Obviously all stocks have been hammered recently, and tech more so, but IPO just don't seem to have had enough winners on their books for a long time.
All tech, and experimental sciences have long lead times for results, but IPO seems to have so few real success stories.
I was wondering what the consensus on the forum was in relation to performance.
Do people see enough IPO investments showing results in the next few years to move the share price by a significant amount, or have we backed a Lemon?
All the best,
B.